Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTern Regulatory News (TERN)

Share Price Information for Tern (TERN)

Share Price is delayed by 15 minutes
Get Live Data
1.20    -0.11 (-8.40%)
Bid:
1.10
Ask:
1.30
Spread: 0.20 (18.182%)
Market Cap: £10.27m
TERN Live PriceLast checked at - London Stock Exchange

Intraday Tern Share Chart

Acquisition update

25 Aug 2011 12:55

RNS Number : 0502N
Silvermere Energy PLC
25 August 2011
 



25 August 2011

 

Silvermere Energy plc

("Silvermere" or "the Company")

 

Acquisition update

 

 

On 15 August 2011, the Company announced that it had received an additional cash call of £250,000 relating to a cost overrun on the re-entry of the I-1 Well in the Mustang Licence Area (all terms in this announcement are as defined in the Company's admission document dated 2 August 2011). The cash call is material in relation to the Company's expected expenditure on the asset and its future working capital requirements.

 

Since the notification of the cash call, Silvermere has been in discussions with the Core Vendors and is pleased to announce that it has now reached agreement with them whereby they will assist the Company with the cash call which, subject to completion of the associated documentation, will allow the transaction to proceed.

 

The Company has agreed that it will pay the cash call but the cost thereof will be repaid to the Company by the Core Vendors in twelve approximately equal instalments commencing on 15 January 2012 (intended to coincide with the expected start of production revenues from the I-1 Well). In addition the Core Vendors have confirmed to the Company that they are unaware of any further cash calls other than those of which the Company is already aware.

 

Under the terms of the acquisition of the Mustang Asset, the Company agreed to issue 676,000 shares to the Core Vendors at Admission. In return for their assistance with the cash call and to facilitate the arrangement referred to below, the Company has agreed to issue 676,000 Placing Warrants to the Core Vendors, on terms identical to those issued to the placees (being one warrant for every share exercisable at 30p for a period of two years following Admission).

 

In order to fund the cash call ahead of its repayment by the Core Vendors, the Company has agreed with t1ps Investment Management (IOM) Limited ("t1ps") and the Core Vendors that, if requested by the Company, they will exercise or procure the exercise of up to 500,000 Placing Warrants in October 2011 (equally split) and, in the case of t1ps only, up to 333,333 Placing Warrants in December 2011. If such undertakings were called upon by the Company, the aggregate proceeds thereof would equal £250,000.

 

These arrangements mean that the effective initial consideration payable by Silvermere remains unchanged at £2.8 million. The number of Placing Warrants to be issued will be 6,755,120 (rather than 6,079,120); the number of Ordinary Shares in issue at Admission is unchanged.

 

T1ps is a substantial shareholder in the Company and as such is a related party under the AIM Rules. In accordance with Rule 13 of the AIM Rules, the Directors, having consulted with the Company's nominated adviser, consider that the undertaking to be given by t1ps as described above, is fair and reasonable insofar as the Company's shareholders are concerned.

 

The Company expects to complete the associated documentation before the adjourned general meeting scheduled for 30 August 2011 and, assuming that shareholders approve the transaction, immediately thereafter to exercise its option to acquire the Mustang Asset. Dealings in the Company's shares and the Pre-CVA Warrants are expected to commence on 31 August 2011.

 

The adjourned general meeting of the Company will be reconvened at 10.30 a.m. on 30 August 2011 at the offices of Memery Crystal LLP, 44 Southampton Buildings, London WC2A 1AP.

 

 

If shareholders do not approve the transaction and as a result the Company is unable to complete the proposed reverse takeover, pursuant to Rule 15, admission of the Company's securities on AIM is due to be cancelled.

 

 

For further information please contact:

 

Silvermere Energy plc

Frank Moxon, Proposed Chairman

Andy Morrison, Proposed Chief Executive

Bruce Evers, Current Executive Chairman

 

 

 

 

+44 (0)1379 640 800

+44 (0)7980 878561

+44 (0)7779 138 471

Merchant Securities Limited (Nominated Adviser and Broker)

Lindsay Mair/Virginia Bull

 

Rivington Street Corporate Finance Limited

Jon Levinson/Dru Edmonstone

 

Old Park Lane Capital

Luca Tenuta

 

 

+ 44(0)20 7628 2200 

 

 

+44 (0)20 7562 3357

 

+44 (0)20 7493 8188

Bishopgate Communications

Nick Rome/Shabnam Bashir

 

+44(0)20 7562 3350

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFELFLFVFEBBZ
Date   Source Headline
8th Jun 20267:00 amRNSNotice of AGM
29th May 20265:00 pmRNSTotal Voting Rights
26th May 20267:00 amRNSInvestment in Talking Medicines CLNs
22nd May 20267:00 amRNSDevice Authority Convertible Loan Notes Investment
19th May 20267:00 amRNSPlacing to raise £222,000
12th May 20267:00 amRNS-RDevice Authority Strategic Partnership
8th May 202612:53 pmRNSResult of GM & Update on Open Offer
8th May 20267:00 amRNSResults of Open Offer
21st Apr 20267:00 amRNSOpen Offer and Notice of General Meeting
31st Mar 20265:00 pmRNSTotal Voting Rights
5th Mar 20267:00 amRNSExtension of loan facility agreement
3rd Mar 20267:00 amRNSResults of Open Offer
13th Feb 20267:00 amRNSOpen Offer at 0.40p to raise up to £384,408
5th Feb 20267:00 amRNS-RTern Notes Automotive Momentum at Device Authority
15th Jan 20267:00 amRNSUpdate regarding SVV2
8th Jan 20267:00 amRNSInvestor Presentations
23rd Dec 20257:00 amRNS-ROnline Investor Presentation and Q&A Session
23rd Dec 20257:00 amRNS-ROnline Investor Presentation and Q&A Session
12th Dec 20257:00 amRNSIssue of Talking Medicines Convertible Loan Notes
28th Nov 20257:00 amRNSUpdate regarding capital commitment to SVV2
25th Nov 20257:00 amRNSTalking Medicines CLN Modifications
31st Oct 20253:35 pmRNSTotal Voting Rights
15th Oct 20257:00 amRNSResults of Open Offer
9th Oct 20257:00 amRNSRemuneration Reductions & Distribution Commitment
29th Sep 20257:00 amRNSOpen Offer to raise up to £642,486
15th Sep 20257:00 amRNSExtension of Loan Facility Term
4th Sep 20257:00 amRNSInterim results for the six months to 30 June 2025
1st Sep 20257:00 amRNSAppointment of shareholder relations adviser
31st Jul 20254:34 pmRNSTotal Voting Rights
29th Jul 20257:00 amRNSResults of underwritten Open Offer & TVR
24th Jul 20257:00 amRNSReceipt of Bridging Loan
14th Jul 20257:00 amRNSUnderwritten Open Offer to raise £642,486
30th Jun 202512:07 pmRNSResult of AGM
13th Jun 20257:00 amRNSDirector Share Purchase
11th Jun 20257:00 amRNSDirector Share Purchase
6th Jun 20257:00 amRNSNotice of AGM and Director Retirement
5th Jun 20257:00 amRNSResults for the year ended 31 December 2024
30th May 20255:39 pmRNSTotal Voting Rights
7th May 20257:00 amRNSResults of Underwritten Open Offer
24th Apr 20257:00 amRNSPurple Transform appointment
17th Apr 20257:00 amRNSUnderwritten Open Offer to raise £340,140
11th Mar 20257:00 amRNS-RDevice Authority Microsoft & CyberArk Partnership
11th Mar 20257:00 amRNS-RSure Ventures Update
28th Feb 20255:00 pmRNSTotal Voting Rights
21st Feb 20257:00 amRNSPlacing to raise £221,154
14th Jan 20257:30 amRNS-RProgressive Equity Research Report
10th Jan 20257:00 amRNSInvestor Presentations
2nd Jan 20257:00 amRNSInvestment in Sure Ventures plc
31st Dec 20241:30 pmRNSTotal Voting Rights
23rd Dec 202411:39 amRNSDevice Authority update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.